SOPHiA GENETICS™ is excited to join the European Congress of Pathology annual meeting, held in person in Dublin, Ireland. Join us at booth #59 from September 10-12 to have the chance to chat with our experts and demo the universal SOPHiA DDM™ Platform.
Mark your agenda on September 11th at 07:15am in room Wicklow Hall 1 for our satellite symposium:
“Unlocking Precision Oncology Insights with Decentralized NGS Data Analysis”
Next-generation sequencing (NGS) has significantly advanced precision oncology approaches by enabling clinicians and researchers to accurately characterize tumor molecular profiles. However, following complex workflows and analyzing large NGS datasets can impact the time to results.
During this symposium, our expert speakers will present their experience with the analytics of the SOPHiA DDM™ Platform applied on real-world cases. In particular, you will learn how the platform can detect complex variants and help you uncover insights and inform data-driven decisions across cancer types.
Decentralizing collective intelligence in precision oncology
Dr. Alex Tuck, SOPHiA GENETICS, Switzerland
Analytical performance of CNV calling prototype for Homologous Recombination Deficiency (HRD) detection
Dr. Maria De Bonis, Health Care Executive, UOS di Diagnostica Molecolare e Genomica, Policlinico Gemelli, Italy
The impact of NGS molecular profiling in Chronic Lymphocytic Leukemia (CLL)
Dr. Dolors Colomer, Senior Consultant, Chief Hematopathology Section, Hospital Clínic Barcelona, Spain
Meet us also on September 11th at 1:00pm at booth #59 to discuss with our experts and industry speakers how the SOPHiA DDM™ Platform can help you – refreshments served.
Add to Calendar
